| 1 |
35221865 | Augustine Blood Group System and Equilibrative Nucleoside Transporter 1. | 2022 Feb |
1 |
| 2 |
34275128 | Differential Inhibition of Equilibrative Nucleoside Transporter 1 (ENT1) Activity by Tyrosine Kinase Inhibitors. | 2021 Sep |
3 |
| 3 |
34382915 | Export of RNA-derived modified nucleosides by equilibrative nucleoside transporters defines the magnitude of autophagy response and Zika virus replication. | 2021 Oct 15 |
6 |
| 4 |
32126230 | HPLC reveals novel features of nucleoside and nucleobase homeostasis, nucleoside metabolism and nucleoside transport. | 2020 Jul 1 |
2 |
| 5 |
32428837 | The Novel Phospholipid Mimetic KPC34 Is Highly Active Against Acute Myeloid Leukemia with Activated Protein Kinase C. | 2020 Jul |
1 |
| 6 |
33142664 | "Open Sesame?": Biomarker Status of the Human Equilibrative Nucleoside Transporter-1 and Molecular Mechanisms Influencing its Expression and Activity in the Uptake and Cytotoxicity of Gemcitabine in Pancreatic Cancer. | 2020 Oct 31 |
1 |
| 7 |
30528800 | Membrane human equilibrative nucleoside transporter 1 is associated with a high proliferation rate and worse survival in resected intrahepatic cholangiocarcinoma patients not receiving adjuvant treatments. | 2019 Jan |
2 |
| 8 |
31235912 | Structures of human ENT1 in complex with adenosine reuptake inhibitors. | 2019 Jul |
4 |
| 9 |
31551431 | Label-free detection of transporter activity via GPCR signalling in living cells: A case for SLC29A1, the equilibrative nucleoside transporter 1. | 2019 Sep 24 |
1 |
| 10 |
31601121 | Effect of hypoxia on human equilibrative nucleoside transporters hENT1 and hENT2 in breast cancer. | 2019 Dec |
1 |
| 11 |
31752123 | hENT1 Testing in Pancreatic Ductal Adenocarcinoma: Are We Ready? A Multimodal Evaluation of hENT1 Status. | 2019 Nov 18 |
1 |
| 12 |
29530865 | Identification of Structural and Molecular Features Involved in the Transport of 3'-Deoxy-Nucleoside Analogs by Human Equilibrative Nucleoside Transporter 3. | 2018 May |
1 |
| 13 |
29864673 | Adenosine causes read-through into the late region of the HPV16 genome in a guanosine-dependent manner. | 2018 Aug |
1 |
| 14 |
30143259 | GnT-V promotes chemosensitivity to gemcitabine in bladder cancer cells through β1,6 GlcNAc branch modification of human equilibrative nucleoside transporter 1. | 2018 Sep 18 |
1 |
| 15 |
30254099 | Role of cysteine 416 in N-ethylmaleimide sensitivity of human equilibrative nucleoside transporter 1 (hENT1). | 2018 Oct 31 |
3 |
| 16 |
30469356 | mRNA Expression and Activity of Nucleoside Transporters in Human Hepatoma HepaRG Cells. | 2018 Nov 21 |
1 |
| 17 |
27995448 | Functional characterization of human equilibrative nucleoside transporter 1. | 2017 Apr |
2 |
| 18 |
28218790 | Differential expression of hENT1 and hENT2 in colon cancer cell lines. | 2017 Feb 16 |
1 |
| 19 |
28254415 | Functional reconstitution of human equilibrative nucleoside transporter-1 into styrene maleic acid co-polymer lipid particles. | 2017 May |
2 |
| 20 |
28417642 | Equilibrative nucleoside transporter 1 expression in primary human hepatocytes is highly variable and determines uptake of ribavirin. | 2017 Apr |
1 |
| 21 |
28729424 | Molecular determinants of acidic pH-dependent transport of human equilibrative nucleoside transporter 3. | 2017 Sep 8 |
1 |
| 22 |
27009875 | Novel regulation of equlibrative nucleoside transporter 1 (ENT1) by receptor-stimulated Ca2+-dependent calmodulin binding. | 2016 May 15 |
2 |
| 23 |
27422302 | SLC29A1 (ENT1) polymorphisms and outcome of complete remission in acute myeloid leukemia. | 2016 Sep |
1 |
| 24 |
27480168 | N-linked glycosylation of N48 is required for equilibrative nucleoside transporter 1 (ENT1) function. | 2016 Aug |
3 |
| 25 |
27906634 | Extended exposure to substrate regulates the human equilibrative nucleoside transporter 1 (hENT1). | 2016 Dec |
3 |
| 26 |
25519698 | Interactions of multitargeted kinase inhibitors and nucleoside drugs: Achilles heel of combination therapy? | 2015 Jan |
1 |
| 27 |
25713072 | A metal-containing nucleoside that possesses both therapeutic and diagnostic activity against cancer. | 2015 Apr 10 |
1 |
| 28 |
25713533 | Nucleoside transporter proteins as biomarkers of drug responsiveness and drug targets. | 2015 |
1 |
| 29 |
25725289 | Adenosine A1 receptor activation modulates human equilibrative nucleoside transporter 1 (hENT1) activity via PKC-mediated phosphorylation of serine-281. | 2015 May |
3 |
| 30 |
25896650 | Lack of the nucleoside transporter ENT1 results in the Augustine-null blood type and ectopic mineralization. | 2015 Jun 4 |
3 |
| 31 |
26070128 | Equilibrative Nucleoside Transporters 1 and 4: Which One Is a Better Target for Cardioprotection Against Ischemia-Reperfusion Injury? | 2015 Jun |
1 |
| 32 |
26162242 | Expression, purification and functional characterization of human equilibrative nucleoside transporter subtype-1 (hENT1) protein from Sf9 insect cells. | 2015 Oct |
2 |
| 33 |
26688730 | Decreased erythrocyte nucleoside transport and hENT1 transporter expression in glucose 6-phosphate dehydrogenase deficiency. | 2015 |
1 |
| 34 |
24163005 | The adenosine transporter, ENT1, in cardiomyocytes is sensitive to inhibition by ethanol in a kinase-dependent manner: implications for ethanol-dependent cardioprotection and nucleoside analog drug cytotoxicity. | 2014 |
4 |
| 35 |
24522200 | Identification of primary equilibrative nucleoside transporter 1 mRNA isoforms resulting from alternative promoter usage in human hepatocytes. | 2014 |
1 |
| 36 |
24788480 | Synthesis of purine and 7-deazapurine nucleoside analogues of 6-N-(4-Nitrobenzyl)adenosine; inhibition of nucleoside transport and proliferation of cancer cells. | 2014 Sep |
3 |
| 37 |
24976360 | Oxidative stress modulates nucleobase transport in microvascular endothelial cells. | 2014 Sep |
1 |
| 38 |
22349506 | PPARα and PPARγ regulate the nucleoside transporter hENT1. | 2012 Mar 9 |
1 |
| 39 |
22644860 | Variability of gemcitabine accumulation and its relationship to expression of nucleoside transporters in peripheral blood mononuclear cells. | 2012 May |
1 |
| 40 |
22985987 | Levels of human equilibrative nucleoside transporter-1 are higher in proliferating regions of A549 tumor cells grown as tumor xenografts in vivo. | 2012 Nov |
1 |
| 41 |
21382338 | Targeted impairment of thymidine kinase 2 expression in cells induces mitochondrial DNA depletion and reveals molecular mechanisms of compensation of mitochondrial respiratory activity. | 2011 Apr 8 |
1 |
| 42 |
21402067 | The life cycle of human equilibrative nucleoside transporter 1: from ER export to degradation. | 2011 Jul 1 |
1 |
| 43 |
21809900 | The Equilibrative Nucleoside Transporter (ENT1) can be phosphorylated at multiple sites by PKC and PKA. | 2011 Sep |
1 |
| 44 |
21443122 | Downregulation of human equilibrative nucleoside transporter 1 by RNAi enhances 5-fluorouracil response in pancreatic cancer. | 2010 Nov-Dec |
2 |
| 45 |
19116148 | Identification of a novel point mutation in ENT1 that confers resistance to Ara-C in human T cell leukemia CCRF-CEM cells. | 2009 Jan 22 |
1 |
| 46 |
19244331 | Reduced ribavirin antiviral efficacy via nucleoside transporter-mediated drug resistance. | 2009 May |
1 |
| 47 |
19699178 | Disrupted plasma membrane localization and loss of function reveal regions of human equilibrative nucleoside transporter 1 involved in structural integrity and activity. | 2009 Oct |
2 |
| 48 |
18078872 | Modulation of the human equilibrative nucleoside transporter1 (hENT1) activity by IL-4 and PMA in B cells from chronic lymphocytic leukemia. | 2008 Feb 15 |
1 |
| 49 |
18589402 | Adenoviral-mediated overexpression of human equilibrative nucleoside transporter 1 (hENT1) enhances gemcitabine response in human pancreatic cancer. | 2008 Aug 1 |
3 |
| 50 |
17121826 | Molecular determinants of substrate selectivity of a novel organic cation transporter (PMAT) in the SLC29 family. | 2007 Feb 2 |
2 |